Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drug conjugates
Biotech
CytomX reports patient death from kidney injury in ADC trial
A patient has died from kidney injury in a trial of CytomX’s lead ADC, although the biotech has been advised to stick with the study.
James Waldron
Aug 14, 2025 6:45am
Ipsen hands back Sutro's ROR1 ADC at center of $875M deal
Aug 8, 2025 6:15am
Minghui raises $131M to fund JAK inhibitor launch, ADC trials
Aug 7, 2025 8:15am
Boehringer 'crossing fingers' ahead of 2 key FDA approvals
Jul 24, 2025 3:00am
ADC Therapeutics shutters UK R&D site, lays off 30% of staff
Jun 12, 2025 3:00pm
Embattled Elevation is latest biotech to accept Concentra buyout
Jun 9, 2025 10:25am
